King Pharmaceuticals Reaches $38M Settlement

Law360, New York (August 7, 2006, 12:00 AM EDT) -- Hoping to bring an end to a securities class action suit, drug company King Pharmaceuticals Inc. reached a $38.25 million settlement deal on Friday.

The settlement is subject to court approval.

The company stated that it believes the amount will be paid by its insurance carriers. It also said that the agreement does not address other previously disclosed lawsuits that are part of a U.S. Securities and Exchange Commission investigation.

The suit, filed on the behalf of persons who acquired King Pharmaceuticals stock between Feb. 16,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.